U.S. to Train Ugandans in Biomedical Research

Uganda has signed a partnership with United States government for extensive training and cooperation in biomedical research, and Chimp Corps report.

This followed talks between Science, look Technology and Innovation Minister Ellioda Tumwesigye and Ambassador Jimmy Kolker, information pills the Deputy Secretary of the U.S. Department of Health and Human Services.

This is the equivalent of the State Minister of Health in Uganda.

The Ambassador recognised Uganda as a leader in managing epidemics, including HIV/AIDS and Ebola.

Minister Tumwesigye and Kolker discussed opportunities for enhancing Uganda’s participation in research indispensable for Global Health Security and the fight against the potential for bio-terrorism.

Speaking to the media on Thursday, Tumwesigye said Dr. Peter Ndemere, the Executive Secretary of Uganda National Council for Science and Technology (UNCST) and Dr. Francis Collins (Director National Institutes of Health (NIH), signed a Memorandum of Understanding (MoU) for the training of more Ugandans in biomedical research and product development.

The NIH biomedical research funding commitment to Uganda in 2016 amounts to approximately US$ 41 million.

Uganda is the second largest recipient of NIH grants, after South Africa.


Tumwesigye said an opportunity for cooperation in materials science and nanotechnology was identified for Ugandan scientists to work with scientists at Massachusetts Institute of Technology (MIT) and the U.S. National Science Foundation.

The Minister highlighted the need to “cooperate in the use of nanotechnology to improve health diagnostics and advanced medical treatment of various diseases.”

At MIT, the Minister was shown innovations created by farmers in Pader and Soroti Uganda and told of the community innovation centers MIT scientists are establishing in collaboration with Ugandans in various parts of Uganda.

The Global Health Security Agenda (GHSA) is a global effort to minimise misuse of potentially dangerous pathogens such as Ebola and Anthrax.

Of particular interest was the need to keep stockpiles of the small pox virus to be available for future development of more effective vaccines and other measures just in case some unscrupulous persons re-engineer the small pox virus and use it as bioweapon.

The two parties also agreed to make a collective effort to prevent antimicrobial resistance, and share information on the safety of genetically modified organisms, whether for food or medicine.

Back to top button
Translate »

Adblock Detected

Please consider supporting us by disabling your ad blocker